Dataset on bilateral idiopathic carpal tunnel syndrome: Crossover study of two combined physiotherapeutic treatment methods on chirurgical and clinical patients.

This study presents a randomized controlled crossover experiment involving 73 patients with idiopathic bilateral Carpal Tunnel Syndrome (CTS). Patients received two combined physiotherapeutic treatments: myofascial mobilization (IASTM) and stretching. Participants were divided into two groups: one started with stretching followed by IASTM, and the other with IASTM followed by stretching. Of these, 43 underwent surgery and began physical therapy 30 days post-operation, while 30 received non-surgical treatment. The therapy sessions lasted four weeks, followed by a crossover of the treatment modalities and periodic reassessments up to six months. The dataset includes experimental design, patient demographics, diagnostic data, objective muscle strength tests, subjective sensitivity tests, clinical indicators, and self-reported measures. This data can be useful for researchers looking to replicate the study or compare outcomes between clinical and surgical CTS patients.

Bilateral Idiopathic Carpal Tunnel Syndrome: Clinical-Functional Characterization and Efficacy of Two Combined Postoperative Physiotherapeutic Treatments.

OBJECTIVE: To evaluate the efficacy of combined association instrument myofascial mobilization (IASTM) and stretching in patients with idiopathic bilateral carpal tunnel syndrome (CTS) operated on one hand and to analyze the response of the operated (OH) and non-operated (NH) hand according to the sequence of therapies. Research on these parameters has not yet been found in the literature. METHODS: Randomized controlled crossover study with 43 participants using the objective and subjective outcome variables. Patients were randomly assigned to two groups: starting with stretching followed by IASTM and starting with IASTM followed by stretching. Then patients underwent surgery on the hand with more severe involvement and physical therapy rehabilitation was started 30 days after for a period of 4 weeks. After the 1-week interval the participants who started with stretching were referred to IASTM and vice versa, following the same previous patterns. The outpatient reassessments took place at 3 to 6 months. Crossover ANOVA and effect sizes were used as analysis methods. RESULTS: Time was the most significant outcome for all variables both during therapies and at 6-month follow-up. Regarding response to the combined therapies between OH and NH, there were differences for both OH and NH, with the greatest impact on NH for the palmar grip and VAS variables. The treatment sequences were significant for pain on the NH and mental SF-12, suggesting that starting with IASTM followed by stretching had a superior outcome for these outcomes. CONCLUSION: The combination of IASTM with stretching, used in the postoperative period of bilateral idiopathic CTS, proved to be supplementary, with significant results and large effect sizes for most of the outcomes assessed, both during the time of application of the therapies and in the 6-month follow-up for both hands, and may constitute a viable therapeutic alternative for this population.

Avaliação da cicatrização de queimaduras utilizando a Escala de Avaliação Cicatricial do Paciente e Observador (POSAS) / Evaluation of burn healing using the Patient and Observer Scar Assessment Scale (POSAS)

OBJETIVO: Avaliar o processo de cicatrização de queimaduras de 2º e 3º graus utilizando a Escala de Avaliação Cicatricial do Paciente e Observador (POSAS) em ambulatório especializado. MÉTODO: Estudo prospectivo de abordagem quantitativa. Participaram 30 pacientes atendidos no ambulatório do Centro de Tratamento de Queimados que sofreram queimaduras de 2º e 3º grau. Foram realizadas 97 avaliações usando a escala POSAS entre julho de 2019 e março de 2020. Para análise estatística, utilizou-se o coeficiente de correlação de Sperman e de equações de estimação generalizadas (GEE), o nível de significância adotado foi p<0,05. RESULTADOS: Houve associação entre as variáveis raça/cor (p<0,001), enxerto (p<0,001), tempo de internação maior do que 21 dias (p=0,009) e lesões de 3º grau (p=0,007), sendo preditores de pior cicatrização. Os itens da escala: saliência (Rho=0,360, p<0,001), irregularidade (Rho=0,262, p<0,05) e área de superfície (Rho=0,223, p<0,05) aumentaram com o tempo de avaliação e a vascularização (Rho=-0,442, p<0,001) diminuiu. A avaliação do observador e do paciente foram semelhantes com relação aos itens: saliência e irregularidade (Rho= 0,526, p<0,001), pigmentação e cor (Rho 0,314, p=0,002) e flexibilidade e rigidez (Rho 0,487, p<0,001) CONCLUSÕES: O uso da escala POSAS permitiu avaliar a evolução do processo de cicatrização e identificar a dinâmica de avaliação do observador e do paciente, que se mostrou semelhante, assim, favorecendo uma assistência individualizada e sistematizada.

OBJECTIVE: To evaluate the healing process of 2nd and 3rd degree burns using the Patient and Observer Scar Assessment Scale (POSAS) in a specialized outpatient clinic. METHODS: Cross-sectional research with a quantitative approach. Participated 30 patients seen at the ambulatory of the Burn Treatment Unit that suffered from 2nd and 3rd degree burns. 97 evaluations were conducted using the POSAS between July of 2019 and March of 2020. For the statistical analysis, the Sperman's correlation coefficient and generalized estimation equations (GEE) were used, the significance level adopted was p<0.050. RESULTS: There was association between the variables race/color (p<0.001), graft (p<0.001), hospitalization time greater than 21 days (p=0.009) and 3rd degree wounds (p=0.007), being predictors of worse healing. The items of the scale: thickness (Rho=0.360, p<0.001), irregularity (Rho=0.262, p<0.5) and surface area (Rho=0.223, p<0.05) increased with evaluation time, and vascularization (Rho= -0.442, p<0.001) decreased. The observer and patient evaluation were similar with the following items: thickness and irregularity (Rho=0.526, p<0.001), pigmentation and color (Rho=0.314, p=0.002), flexibility and rigidity (Rho=0.487, p<0.001). CONCLUSIONS: The use of the POSAS Scale allowed to evaluate the evolution of the healing process and to identify the evaluation dynamic between observer and patient during the burn recovery process, which proved to be similar, favoring individualized and systemic care.

Impact of plantar fasciitis on postural control and walking in young middle-aged adults.

PURPOSE: To assess if plantar fasciitis has an impact on postural control and walking pattern from gait analysis across different experimental conditions. METHODS: Thirty participants (n = 15 with plantar fasciitis) performed 5 different balance tasks on a force platform, and the center of pressure (COP) was computed for postural control analysis. Participants were also asked to walk at 3 different speeds on a gait analysis system to compute the spatial-temporal parameters. Clinical foot measurements (pain, mobility) were also collected through all participants. RESULTS: Clinical foot measurements showed no significant difference between the two groups; except for pain palpation in plantar fasciitis group. Significant differences were observed between the two groups for COP area displacement sway (p < 0.01; d = 0.08) and velocity (p = 0.022; d = 0.04), where the fasciitis group reported poorer postural control than control mainly during more challenging balance tasks (semi-tandem, unipodal). Plantar fasciitis group reported a decrease of gait velocity (p < 0.01; d = 0.12), step length (p < 0.01; d = 0.16) and step width (p < 0.01; d = 0.18) when compared to the healthy group across walking speed tests. CONCLUSIONS: Individuals with plantar fasciitis report poor postural control and changes in walking pattern across three speeds performance.

USE OF MOUTHWASH AND DENTIFRICE CONTAINING AN ANTIMICROBIAL PHTHALOCYANINE DERIVATIVE FOR THE REDUCTION OF CLINICAL SYMPTOMS OF COVID-19: A RANDOMIZED TRIPLE-BLIND CLINICAL TRIAL.

PURPOSE: This clinical trial aimed to evaluate the use of mouthwash and dentifrice containing an antimicrobial phthalocyanine derivative (APD) to reduce the clinical symptoms in patients with COVID-19. METHODS: This randomized, triple-blind clinical trial enrolled 134 patients aged 18 years or older who underwent COVID-19 testing through the use of nasopharyngeal swab RT-qPCR in a reference center for the diagnosis of COVID-19, had no clinical contraindications to mouthwash and gargle, and had access to cell phones with communication applications. According to the use of a mouthwash and dentifrice containing antimicrobial phthalocyanine derivatives (APD), patients were randomly assigned (1:1) to the APD or non-APD (control) group. All participants were instructed to floss twice a day, brush teeth for 2 minutes 3 times a day, and gargle/rinse (5 mL) for 1 min/3 times a day for 7 days. An online questionnaire was sent to collect data on the clinical symptoms of COVID-19 3 times: T0 (baseline before using the oral hygiene products), T3 (3 days after), and T7 (7 days after). The investigators, patients, and outcome assessors were blinded to group assignment. The Mann-Whitney, Chi-Square, Fisher's exact, and Cochran's tests were used according to the nature of the variables studied, with the level of significance set at P < .05. RESULTS: No statistically significant difference was found in the prevalence of symptoms between groups at baseline. A statistically significant reduction in clinical symptoms was found in the control group (fatigue, shortness of breath, hoarse voice, sore throat, nasal congestion, and chest pain) and APD group (cough, fatigue, shortness of breath, hyposmia/anosmia, dysgeusia, hoarse voice, sore throat, nasal congestion, chest pain, diarrhea, and irritability/confusion) during the follow-up period. There were statistically significant differences, with a higher prevalence of symptoms in the control group at T3 and T7. Dysgeusia, sore throat, and irritability/confusion were less prevalent in the APD group at T3, and shortness of breath, hyposmia/anosmia, dysgeusia, hoarse voice, sore throat, diarrhea, and irritability/confusion were more prevalent in the control group at T7. CONCLUSIONS: Based on this methodology, the results demonstrated that the regular use of mouthwash and dentifrice-containing APD had a positive impact on the clinical symptoms, as reported by patients with COVID-19.

Towards the Objective Identification of the Presence of Pain Based on Electroencephalography Signals' Analysis: A Proof-of-Concept.

This proof-of-concept study explores the potential of developing objective pain identification based on the analysis of electroencephalography (EEG) signals. Data were collected from participants living with chronic fibromyalgia pain (n = 4) and from healthy volunteers (n = 7) submitted to experimental pain by the application of capsaicin cream (1%) on the right upper trapezius. This data collection was conducted in two parts: (1) baseline measures including pain intensity and EEG signals, with the participant at rest; (2) active measures collected under the execution of a visuo-motor task, including EEG signals and the task performance index. The main measure for the objective identification of the presence of pain was the coefficient of variation of the upper envelope (CVUE) of the EEG signal from left fronto-central (FC5) and left temporal (T7) electrodes, in alpha (8-12 Hz), beta (12-30 Hz) and gamma (30-43 Hz) frequency bands. The task performance index was also calculated. CVUE (%) was compared between groups: those with chronic fibromyalgia pain, healthy volunteers with "No pain" and healthy volunteers with experimentally-induced pain. The identification of the presence of pain was determined by an increased CVUE in beta (CVUEß) from the EEG signals captured at the left FC5 electrode. More specifically, CVUEß increased up to 20% in the pain condition at rest. In addition, no correlation was found between CVUEß and pain intensity or the task performance index. These results support the objective identification of the presence of pain based on the quantification of the coefficient of variation of the upper envelope of the EEG signal.

The importance of optimal 25-hydroxyvitamin D levels in the glycemic control of older adults with type 2 Diabetes Mellitus: Data from the study on aging and longevity EELO

INTRODUCTION: Optimal serum levels of vitamin D are of great importance, especially in populations with comorbidities such as Diabetes Mellitus (DM). OBJECTIVE: The study evaluated the relationship between hypovitaminosis D and glycemic control in older adults with type 2 DM. METHODS: Cross-sectional and prospective study, part of the EELO project (Study on Aging and Longevity), conducted in Southern Brazil. Glycated hemoglobin (diabetes ≥6.5%) and serum levels of vitamin D (25(OH)D) were evaluated. Hypovitaminosis D was determined using cutoff points <20 and <30 ng/mL). Multivariate logistic regression was used to assess the risk of having uncontrolled DM. RESULTS: Of the 120 older adults included in the study, aged between 60 and 87 years, 74.2% were women, 66.7% used hypoglycemic medications and 75.8% exhibited uncontrolled diabetes. An inverse correlation was observed between the levels of 25(OH) D and glycated hemoglobin (rS=-0.19, p=0.037), suggesting that low levels of vitamin D are associated with poor glycemic control in diabetic individuals. The prevalence of hypovitaminosis D when using the cutoff points of <20 and <30 ng/mL were 34.2% and 75.0%, respectively. The odds ratio (OR) analysis showed that individuals with 25(OH)D<20ng/mL have almost 4 times more risk of having uncontrolled DM (OR:3.94; CI95%:1.25-12.46, p=0.02) when compared to the older adults with sufficient levels of vitamin D. CONCLUSION: The results indicate that the optimal serum levels currently recommended for 25(OH)D should preferably be 30 ng/mL or higher to contribute to better glycemic control in older adults with type 2 DM.

INTRODUÇÃO: Os níveis séricos ideais de vitamina D são de grande importância, especialmente na população com comorbidades como o Diabetes Mellitus (DM). OBJETIVO: O estudo avaliou a relação entre hipovitaminose D e controle glicêmico em idosos com DM tipo 2. MÉTODOS: Estudo transversal e prospectivo, parte do projeto EELO (Estudo sobre Envelhecimento e Longevidade), no Sul do Brasil. A hemoglobina glicada (diabetes ≥6,5%) e os níveis séricos de vitamina D (25(OH)D) foram avaliados. Hipovitaminose D foi determinada usando ponto de corte <20 e <30 ng/mL. Regressão logística multivariada foi utilizada para avaliar o risco de ter DM descompensado. RESULTADOS: Dos 120 idosos incluídos no estudo, idade entre 60 a 87 anos, 74,2% eram mulheres, 66,7% faziam uso de medicamentos hipoglicemiantes e 75,8% apresentavam diabetes descompensada. Uma correlação inversa foi observada entre os níveis de 25(OH)D e hemoglobina glicada (rS=-0,19; p=0.037), sugerindo que baixos níveis de vitamina D está associado a um pior controle glicêmico em diabéticos. A prevalência de hipovitaminose D quando se utiliza ponto de corte <20 e <30 ng/mL foi de 34,2% e 75,0%, respectivamente. A análise Odds ratio (OR) mostrou que indivíduos com 25(OH)D<20 ng/mL tem quase 4 vezes mais risco de ter DM descompensado (OR:3,94; IC95%:1,25­12,46; p=0,02) quando comparado aos idosos com níveis suficientes de vitamina D. CONCLUSÃO: Os resultados indicam que os níveis sérios ideais atualmente recomendados para 25(OH)D maior ou igual a 30 ng/ml contribuem para o melhor controle glicêmico na população idosa com DM tipo 2.

Evaluation of ApaI and FokI polymorphism of VDR gene and functional characterization in patients with fibromyalgia / Avaliação do polimorfismo ApaI e FokI do gene VDR e caracterização funcional em pacientes com fibromialgia

Abstract Introduction: Fibromyalgia (FM) is a syndrome of unknown origin characterized by several symptoms, and although its pathogenesis has not been completely elucidated, it seems to be related to inflammatory path-ways and neurochemical changes in the brain. Objective: To evaluate the association between BsmI, ApaI and FokI polymorphisms of the vitamin D receptor (VDR) gene, their polymorphisms, and clinical variables in women with and without FM. Methods: This is a case-control study composed of a group of 53 women with FM and another with 40 women without the disease. The McGill Pain Questionnaire, Fibromyalgia Impact Questionnaire, Pain Visual Analogue Scale and the sit-up test were applied. Real-time PCR was performed to analyze the ApaI and FokI polymorphism. Results: There was a statistical association between race, comorbidity and FM, where 78.4% of the individuals were white and had FM (p < 0.002) and 96.1% had some comorbidity (p < 0.001). Seventy-six point five percent (76.5%) of patients with FM underperformed in the sit-up test (p < 0.001). There was also an association between the genotypic and allele frequencies of the VDR and FM gene Apal and FokI polymorphisms (p < 0.001). In the VDR gene ApaI polymorphism, the CC genotype exhibited a higher frequency in women with FM, the C allele for the Apal polymorphism was 3.33 times more likely, and the FokI polymorphism was 10.9 times more likely to develop FM (p < 0,0001). Conclusion: Women with C allele for ApaI polymorphism are 3.33 times more likely to have FM (95%CI = 1.58-7.02; p = 0.0024), and in FokI polymorphism, the prevalence of T allele is 10.9 times greater (95% CI = 4.76-25.38; p < 0.0001). No significant associations were found in relation to BsmI polymorphism and frequency alleles (p = 0.062 and p = 0.078, respectively).

Resumo Introdução: A fibromialgia (FM) é uma síndrome de origem desconhecida caracterizada por diversos sintomas, e embora sua patogênese não tenha sido completamente elucidada, parece estar relacionada às vias inflamatórias e alterações neuroquímicas no cérebro. Objetivo: Avaliar a associação entre os polimorfismos BsmI, ApaI e FokI do gene do receptor da vitamina D (VDR), seus polimorfismos e variáveis clínicas em mulheres com e sem FM. Métodos: Trata-se de um estudo caso-controle composto por um grupo de 53 mulheres com FM e outro com 40 mulheres sem a doença. Foram aplicados o Questionário de Dor de McGill, Questionário de Impacto da Fibromialgia, Escala Visual Analógica da Dor e o teste de sentar. A PCR em tempo real foi realizada para analisar o polimorfismo ApaI e FokI. Resultados: Houve associação estatística entre raça, comorbidade e FM, onde 78,4% dos indivíduos eram brancos e apresentavam FM (p < 0,002) e 96,1% tinham alguma comorbidade (p < 0,001). Setenta e seis vírgula cinco por cento (76,5%) dos pacientes com FM tiveram desempenho inferior no teste de abdominais (p < 0,001). Também houve associação entre as frequências genotípicas e alélicas dos polimorfismos Apal e FokI do gene VDR e FM (p < 0,001). No polimorfismo ApaI do gene VDR, o genótipo CC apresentou maior frequência em mulheres com FM, o alelo C para o polimorfismo Apal foi 3,33 vezes mais provável, e o polimorfismo FokI teve 10,9 vezes mais chance de desenvolver FM (p < 0,0001). Conclusão: Mulheres com alelo C para polimorfismo ApaI têm 3,33 vezes mais chance de ter FM (IC 95% = 1,58-7,02; p = 0,0024), e no polimorfismo FokI, a prevalência do alelo T é 10,9 vezes maior (IC 95% = 4,76-25,38; p < 0,0001). Não foram encontradas associações significativas em relação ao polimorfismo BsmI e alelos de frequência (p = 0,062 e p = 0,078, respectivamente).

Sobrevida e fatores associados à mortalidade de pacientes com internações de longa permanência / Survival and mortality time of patients with long-stay hospitalizations in a hospital of high complexity / Supervivencia y factores asociados a la mortalidad en pacientes con hospitalizaciones de larga duración

Objetivo: Analisar a sobrevida e os fatores associados à mortalidade de pacientes com internações de longa permanência. Método: Estudo transversal, a partir de registros dos pacientes que tiveram internação de longa permanência, em hospital de alta complexidade, pelo Sistema Único de Saúde, de 2014 a 2017, com exclusão das reinternações. Utilizou-se a Regressão de Cox para identificação dos fatores associados à mortalidade. Dentre os pacientes internados na Unidade de Terapia Intensiva aplicou-se a curva Roc para determinar o ponto de corte do dia de maior risco de óbito. Resultados: Foram identificadas 1.209 internações de longa permanência resultando em prevalência de 7,3%. Do total de pacientes de longa permanência, 50,3% foram a óbito, a maioria com idade superior a 60 anos, com doenças do aparelho circulatório (40%). Os fatores associados à mortalidade dos pacientes com internação de longa permanência foram: ser idoso (HR=2,31; IC95%:1,89-2,81; p<0,001); internação clínica (HR=1,82; IC95%: 1,54-2,15; p<0,001) e internação em UTI (HR=12,41; IC95%: 6,74-22,8; p<0,001). A mortalidade dos pacientes que foram internados na Unidade de Terapia Intensiva foi significativamente maior a partir do nono dia (p = 0,036). Conclusão: Verificou-se uma alta taxa de mortalidade em pacientes com internação de longa permanência, principalmente, entre idosos com doenças crônico-degenerativas e em cuidados paliativos. (AU)

Objective: To analyze the survival time and factors associated with the mortality of patients with long-stay hospitalizations in a hospital of high complexity. Methods: Cross-sectional study. We included records of patients who had long-term hospitalization for the Unified Health System between 2014 and 2017, excluding rehospitalizations. Cox Regression was used to identify the factors associated with mortality. Still, among the patients who were admitted to the intensive care unit, the Roc curve was used to determine the cutoff point to identify the day on which the patients had a higher risk of death. Results: 1,209 long-stay hospitalizations were identified, resulting in a prevalence of 7.3%. Of the total long-stay patients, 50.3% died. The majority were over 60 years old, with diseases of the circulatory system (40%). The factors associated with the mortality of patients with long-term hospitalization were: elderly (HR = 2.31; 95% CI: 1.89-2.81); clinical hospitalization (HR = 1.82, 95% CI: 1.54-2.15); ICU admission (HR = 12.41, 95% CI: 6.74-22.8). Mortality of patients admitted to the intensive care unit was significantly higher after the ninth day (p = 0.036). Conclusion: There was a high mortality rate in patients with long-term hospitalization, mainly among elderly people with chronic degenerative diseases and in palliative care. (AU)

Objetivo: Analizar la supervivencia y los factores asociados a la mortalidad en pacientes con hospitalizaciones de larga duración. Métodos: Estudio transversal, basado en registros de pacientes que tuvieron hospitalización de larga duración en un hospital de alta complejidad, a través del Sistema Único de Salud, de 2014 a 2017, excluyendo reingresos. Se utilizó la regresión de Cox para identificar los factores asociados con la mortalidad. Entre los pacientes ingresados en la Unidad de Cuidados Intensivos se aplicó la curva de Roc para determinar el punto de corte del día con mayor riesgo de muerte. Resultados: Se identificaron 1.209 hospitalizaciones de larga duración, lo que resultó en una prevalencia del 7,3%. Del total de pacientes de larga evolución falleció el 50,3%, la mayoría mayores de 60 años, con enfermedades del sistema circulatorio (40%). Los factores asociados a la mortalidad de los pacientes con hospitalización de larga duración fueron: anciano (HR=2,31; IC95%:1,89-2,81); hospitalización clínica (HR=1,82; IC95%: 1,54-2,15) e ingreso a una unidad de cuidados intensivos (HR=12,41; IC95%: 6,74-22,8). Conclusion: La mortalidad de los pacientes que ingresaron en la Unidad de Cuidados Intensivos fue mayor a partir del noveno día (p=0,036). Se identificó una alta tasa de mortalidad en pacientes con hospitalización de larga duración, especialmente entre personas mayores con enfermedades crónico-degenerativas y en cuidados paliativos. (AU)

Impact of physical and functional fitness on mortality from all causes of physically independent older adults.

OBJECTIVE: To provide reference values for functional fitness tests (PFFT) and verify the capability of these tests alone and grouped into a general index (GFFI-6), to predict mortality from all causes, during seven years of follow-up of physically independent older adults. METHODS: The sample consisted of 422 older adults, evaluated at baseline using six PFFTs, as well as sociodemographic, behavioral, anthropometric, and comorbidity variables. Mortality from all causes was followed for seven subsequent years. The sample was subdivided into four groups according to sex and age. Performances in the PFFT and GFFI-6 tests were ranked into "low", "regular", and "high". RESULTS: Cox proportional regression, with the adjustment of variables, indicated that the Unipedal Balance Test (BAL), Body Agility (AGI), Sit and Stand-up (SIT-SD) tests, and GFFI-6 were able to significantly predict mortality, indicating that older adults with "low" performance have, respectively, a 2.7 (CI=1.54-4.89, p = 0.01), 4.2 (CI=2.10-8.41), 2.5 (CI=1.44-4.65, p = 0.01), and 4.7 (CI=2.10-10.81, p<0.01) times higher risk of death, compared to older adults with "high" performance. CONCLUSION: BAL, AGI, and SIT-SD tests alone and tests grouped in the GFFI-6 were strong predictors of all-cause mortality in physically independent older adults.